{"nct_id":"NCT02173704","title":"Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.","status":"COMPLETED","status_verified_date":"2020-08","start_date":"2014-09-11","start_date_type":"ACTUAL","primary_completion_date":"2015-12-25","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}